How do I buy shares of JNX?
Shares of JNX and other Canadian stocks can be purchased through an online brokerage account.
How much is a share of Junex worth?
One share of JNX stock can currently be purchased for approximately C$0.41. How much money does Junex make? Junex has a market capitalization of C$36.33 million.
Where is Junex located?
Junex is headquartered at 2795 Laurier Blvd Bureau 200, QUEBEC, QC G1V 4M7, Canada. How can I contact Junex?
Who are Junex's key executives?
Junex's management team includes the following people: Mr. Jean-Yves Lavoie , Co-Founder, Pres, CEO & Chairman Mr. François Lévesque , CFO & Acc...
Who are some of Junex's key competitors?
Some companies that are related to Junex include Petroteq Energy (PQE) , Iron Bridge Resources (IBR) , IOG (IOG) , Phoenix Global Resources (PG...
What other stocks do shareholders of Junex own?
Based on aggregate information from My MarketBeat watchlists, some companies that other Junex investors own include IGM Financial (IGM) , ProShar...
What is Junex's stock symbol?
Junex trades on the Canadian Venture Exchange (CVE) under the ticker symbol "JNX."
How do I buy shares of Junex?
Shares of JNX and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian...
What is Junex's stock price today?
One share of JNX stock can currently be purchased for approximately C$0.41.
How much money does Junex make?
Junex has a market capitalization of C$36.33 million.
What is Junex's official website?
The official website for Junex is www.junex.ca .
How can I contact Junex?
Junex's mailing address is 2795 Laurier Blvd Bureau 200, QUEBEC, QC G1V 4M7, Canada . The company can be reached via phone at +1-418-6549661 .
Recently Viewed Tickers
Therma Bright Inc
Visit a quote page and your recently viewed tickers will be displayed here.
Janux Therapeutics to Present Virtually at the H.C. Wainwright BioConnect Conference
Therma Bright, Inc. develops and markets skin care medical device products. Its products include Therapik, which is used to relieve the pain, itch and inflammation of stings and bites from different species of insects and InterceptCS, which is a device to prevent cold sore outbreaks.
We Think Janux Therapeutics (NASDAQ:JANX) Can Afford To Drive Business Growth
SAN DIEGO, January 05, 2022--Janux Therapeutics, Inc.
Janux Therapeutics Reports Business Highlights and Third Quarter 2021 Financial Results
There's no doubt that money can be made by owning shares of unprofitable businesses. For example, biotech and mining...
Janux Therapeutics to Present Virtually at Upcoming Investor Conferences
SAN DIEGO, November 09, 2021--Janux Therapeutics, Inc.
Janux Therapeutics Appoints Ron Barrett, Ph.D., and Alana McNulty to Board of Directors
SAN DIEGO, November 08, 2021--Janux Therapeutics, Inc.
Janux Therapeutics to Present Virtually at the H.C. Wainwright 23rd Annual Global Investor Conference
SAN DIEGO, September 09, 2021--Janux Therapeutics, Inc. (Nasdaq: JANX) (Janux), a biopharmaceutical company developing a broad pipeline of novel immunotherapies by applying its proprietary technology to its Tumor Activated T Cell Engager (TRACTr) and Tumor Activated Immunomodulator (TRACIr) platforms, today announced the additions of Ronald W.
Janux Therapeutics Appoints Shahram Salek-Ardakani, Ph.D., Chief Scientific Officer
SAN DIEGO, September 07, 2021--Janux Therapeutics, Inc.
